Trial intelligence / Profile preview

Levobupivacaine Spinal vs Saddle Block in TURP

NCT06014957Unknown

Sponsor
New Valley University
Start
Aug 2023
Primary completion
Dec 2023
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of levobupivacaine in benign prostatic hyperplasia (BPH) (2 arms), sponsored by New Valley University. Primary endpoint: Mean Arterial Blood Pressure at 24 hours. Status: unknown.

02

Drugs

levobupivacaine
03

Conditions

benign prostatic hyperplasia (BPH)

Beyond the preview

Go deeper on NCT06014957.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06014957.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call